- Home
- PAVM
PAVM
PAVmed Inc.
as of 08-28-2026 3:31pm EST
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 41.4M | IPO Year: | 2015 |
| Target Price: | $65.00 | AVG Volume (30 days): | 32.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.17 | EPS Growth: | -1226.00 |
| 52 Week Low/High: | $0.21 - $28.44 | Next Earning Date: | 05-15-2026 |
| Revenue: | $3,000,000 | Revenue Growth: | 20.00% |
| Revenue Growth (this year): | 603.94% | Revenue Growth (next year): | 33.16% |
| P/E Ratio: | -1.60 | Index: | N/A |
| Free Cash Flow: | -5237000.0 | FCF Growth: | N/A |
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q2 Q2 2026 Earnings
8-K SELL Aug 14, 2026 · 100% conf.
Q2 2026 Earnings
8-K SELLAug 14, 2026 · 100% conf.
1D
-2.35%
$5.08
Act: +2.40%
5D
-9.20%
$4.72
20D
-2.34%
$5.08
Transcript text not available. View on SEC.gov →
2026 Q1 Q1 2026 Earnings
8-K May 15, 2026
Q1 2026 Earnings
8-KMay 15, 2026
2025 Q4 Q4 2025 Earnings
8-K Mar 30, 2026
Q4 2025 Earnings
8-KMar 30, 2026
Compare PAVM vs Leading Stocks
See how PAVM stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PAVM PAVmed Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.